Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
IGC Pharma, Inc. (IGC) had Weighted-Average Shares Outstanding (Diluted) of 58.84M for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
$1.34M |
|
$-13.00M |
|
$0.61M |
|
$0.73M |
|
$11.14M |
|
$-9.80M |
|
$-3.20M |
|
$-13.00M |
|
$-9.65M |
|
$-13.00M |
|
$-13.00M |
|
$-13.00M |
|
$-9.65M |
|
$-9.80M |
|
$-9.16M |
|
58.84M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
58.84M |
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$3.71M |
|
$3.69M |
|
$6.20M |
|
$9.90M |
|
$2.34M |
|
$0.14M |
|
$0.24M |
|
$2.58M |
|
$7.32M |
|
$5.71M |
|
$7.32M |
|
66.69M |
|
| Cash Flow Statement Financials | |
$-5.20M |
|
$-0.32M |
|
$3.52M |
|
$3.20M |
|
$1.20M |
|
$-2.00M |
|
$1.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.58 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
54.50% |
|
-728.48% |
|
-728.48% |
|
-681.12% |
|
-966.54% |
|
-966.54% |
|
$-5.29M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.40 |
|
34.49 |
|
10.58 |
|
-177.57% |
|
-227.87% |
|
-131.29% |
|
-174.31% |
|
$0.11 |
|
$-0.09 |
|
$-0.09 |
|